Intriguingly, STS inhibition also lowered aromatase and 17β-HSD type-1 expression in the tumours, the mechanism of which remains unknown but may suggest hormonal regulation of these enzymes in cancer. This evidence concerns the gene CYP19A1 and neoplasm.